| __timestamp | BioMarin Pharmaceutical Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 25469000000 |
| Thursday, January 1, 2015 | 737887000 | 24564000000 |
| Friday, January 1, 2016 | 907234000 | 25916000000 |
| Sunday, January 1, 2017 | 1071860000 | 27347000000 |
| Monday, January 1, 2018 | 1175948000 | 28785000000 |
| Tuesday, January 1, 2019 | 1344582000 | 32728000000 |
| Wednesday, January 1, 2020 | 1336183000 | 27900000000 |
| Friday, January 1, 2021 | 1375760000 | 35078000000 |
| Saturday, January 1, 2022 | 1612370000 | 41872000000 |
| Sunday, January 1, 2023 | 1842161000 | 43989000000 |
Data in motion
In the competitive landscape of pharmaceuticals, Merck & Co., Inc. and BioMarin Pharmaceutical Inc. have showcased distinct trajectories in gross profit performance over the past decade. From 2014 to 2023, Merck's gross profit surged by approximately 73%, reaching a peak in 2023. This growth underscores Merck's robust market strategies and product innovations. In contrast, BioMarin, while smaller in scale, demonstrated a commendable 196% increase in gross profit during the same period, reflecting its strategic focus on niche markets and rare disease treatments.
Merck's dominance is evident, with its gross profit consistently outpacing BioMarin's by a factor of nearly 20. However, BioMarin's rapid growth trajectory highlights its potential to capture significant market share in specialized sectors. As the pharmaceutical industry evolves, these two companies exemplify the diverse strategies that can lead to financial success.
Who Generates Higher Gross Profit? Merck & Co., Inc. or Pfizer Inc.
Merck & Co., Inc. and Exelixis, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Merck & Co., Inc. and Lantheus Holdings, Inc.
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or BioMarin Pharmaceutical Inc.
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or BioMarin Pharmaceutical Inc.
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Genmab A/S and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Incyte Corporation and BioMarin Pharmaceutical Inc. Trends
BioMarin Pharmaceutical Inc. and Catalent, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? BioMarin Pharmaceutical Inc. or Jazz Pharmaceuticals plc
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Bausch Health Companies Inc.
BioMarin Pharmaceutical Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis